| 查看: 1280 | 回复: 4 | |||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[交流]
急。求助翻译。质量一般就行，不要机译。谢谢
|
|||
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristicsfor improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. Stearic acid based nanoparticles of carvedilol phosphate were fabricated by solvent emulsification evaporation technique in sodium taurocholate solution prepared in pH 7.2 buffers (I—KH2PO4/NaOH or II—NaH2PO4/Na2HPO4) with 1% polyvinyl alcohol. Nanoparticles were then adsorbed by passing the nanodispersion through a Neusilin US2 (adsorbent) column. Interestingly, scanning electron microscopy revealed round deformed and even collapsed nanoparticles in Buffer-I and discrete spherical to ellipsoidal nanoparticles in Buffer-II which indicates the inability of nanoemulsion to crystallize and form SLN in Buffer-I. The successful formation of SLN in Buffer-II was confirmed by differential scanning calorime try and X-ray diffraction. The retention of SLN from the nanodispersion by adsorption on the adsorbent imparted good flow property and resulted in a marked stability improvement of the formulation in terms of drug retention efficiency and release profile as compared to the simple nanosuspension. In conclusion, the adsorbent technology would be instrumental in imparting additional features to the existing conventional colloidal system for pharmaceutical application which would ease the process of capsule filling at industrial scale, simplify the handling of formulations by patients and can significantly improve the shelf life of the product for a longer period of time as compared to liquid formulations. improve stability. However, the coexistence of high concentration of stabilizing agents (surfactants) along with the lipid nanopartiSolid lipid based colloidal carriers of drugs have attracted considerable attention in the last two decades [1–4]. As they are derived from physiologically compatible lipids, solid lipid nanoparticles (SLN) represent a safe and effective alternative which include additional advantages and are devoid of the potential toxicities of conventional polymeric nanoparticles [5–7]. SLN for oral drug administration have specifically been employed for improving bioavailability by targeting the uptake of the drug by lymphatic system which prevents its hepatic first pass metabolism [8–11]. Despite the perceived therapeutic advantages of SLN, the technology available so far for the fabrication of SLN is restricted to the development of nanodispersion which has not had been so encouraging. In an aqueous nanodispersion, the SLN have a tendency to undergo particle aggregation under accelerated storage conditions due to the gelation phenomenon (an irreversible conversion of low viscosity lipid based nanoparticles dispersion into a viscous gel) due to which the dispersion is usually lyophilized into a dry powder to cles (LNs) in the final product is not desirable because of their toxic effects on the mucosal lining of the GIT. Moreover, the process of lyophilization is critical as rate of freezing governs the structure and properties of the lipid crystals which finally determines its drug retention capacity during storage. Alternatively, filtration of the nanoparticles as a whole is a costly and exhaustive process due to the requirement of sophisticated equipments for retaining particles in nanosize range. Apart from the above, surfactants essentially employed in the production of SLN increase solubility of the poorly soluble/insoluble drug in the external phase. This matter is of serious concern during production and upon long term storage as it results in progressive leaching of drug from the particles to external phase which results in reduced drug loading efficiency. The above issues have been discussed in detail in literature [12].The above discussion indicates that there is a necessity to develop a method which can separate the nanoparticles from the dispersion and immobilize them in order to retain their individual morphological identity upon storage. Harvesting the SLN from the nanodispersion by surface adsorption or retention on a submicron size inert pharmaceutical excipient with good flowability, compressibility and adsorption capacity may be an excellent approach to overcome the above mentioned issues. The prepared “Adsorbed Lipid Nanoparticles” (ALN) would not only maintain the integrity of each adsorbed nanoparticle but also ease its filling into capsules or compression into tablet. To our knowledge, such a unique approach in the development of SLN delivery system has not been reported so far. However, limited studies involving the use of adsorbents to obtain lipid based granules for oral drug delivery have been reported wherein adsorbents were found to enhance the bioavailability of the drug and impart significant flow and compressibility to the final blend [13–15].The drug employed here is carvedilol phosphate, a non-selective-blocker. The drug exhibits poor aqueous solubility and highlipophilicity (log P) which makes it an excellent candidate for SLN encapsulation[16,17]. A study conducted previously in our laboratory using different types and concentration of surfactants at different pH has shown that sodium taurocholate (STC) has both minimum molar solubilization capacity and binding constant for carvedilol phosphate at pH 7.2 [18]. Therefore, the objective of the present work was to develop SLN of carvedilol phosphate using STC as a stabilizing agent and pH 7.2 phosphate buffer as dispersion medium, and improve the physicochemical properties of the nanoparticles by adsorbing them onto Neusilin (magnesium aluminometasilicate), an inert pharmaceutical excipient used as adsorbent. 2. Materials and methods [ Last edited by kaichang on 2011-1-9 at 13:15 ] |
回复此楼» 猜你喜欢
一志愿华中农业071010，320求调剂
已经有10人回复
-
材料工程281还有调剂机会吗
已经有43人回复
-
291求调剂
已经有5人回复
-
085801电气专硕272求调剂
已经有18人回复
-
296求调剂
已经有11人回复
-
求调剂学校
已经有14人回复
-
药学求调剂
已经有9人回复
-
复试调剂
已经有22人回复
-
求调剂推荐
已经有5人回复
-
山东省基金2026
已经有10人回复
» 抢金币啦！回帖就可以得到:
-
江西科技师范大学高分子化学与物理招生
+5/760
-
【坐标大连】92年本科男生，寻觅姻缘女生
+5/366
-
供应有机合成一整套设备，有机合成实验室常用产品。
+1/90
-
当新能源不再是一个选择题
+1/90
-
物理学调剂
+1/89
-
华南理工大学微电子学院招博士研究生
+1/85
-
中山大学招聘博士后（化学生物学、蛋白质组学、环境毒理学）
+1/78
-
西安电子科技大学通信工程学院招收 “非全日制 调剂生“
+2/42
-
山东大学杨再兴课题组长期诚聘博士后
+2/40
-
还有名额！！辽石化新材料学院材料专业调剂 理转工 / 学专互调
+1/40
-
山东航空学院安全工程专业085702第三轮接收研究生调剂，欢迎咨询
+1/36
-
省重点实验室招收调剂生（一志愿07开头专业），海洋生物专业名额充足
+1/15
-
接收资源与环境专业硕士调剂
+1/10
-
中科院物理所李泓/吉林大学毛慧灿团队联合诚聘博士后
+1/10
-
省重点实验室招收07专业调剂生，海洋生物专业名额充足
+1/9
-
香港科技大学（广州）杨其纯课题组招收水文学方向博士后研究人员两名
+1/8
-
抗病毒性传染病创新药物全国重点实验室—生物与医药还有3个指标，可跨专业调剂
+1/5
-
江西科技师范大学食品安全检测课题组招收生物学/分析化学学硕调剂生各1名
+1/4
-
北华大学—工学08调剂仍有余额（初试需含数学+英语）
+1/4
-
坐标南京
+1/3
5楼2011-01-10 01:12:07
kaichang(金币+2, 翻译EPI+1):尽管只有一句，不过还是谢谢。有空就全部帮我翻译了吧。 2011-01-09 18:51:36
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristics for improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. 本文的目的是采用能自由流动的吸附剂，来改善作口服剂之用的固体脂质纳米粒的稳定性与物理性能。 |
2楼2011-01-09 17:21:15
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristicsfor improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. Stearic acid based nanoparticles of carvedilol phosphate were fabricated by solvent emulsification evaporation technique in sodium taurocholate solution prepared in pH 7.2 buffers (I—KH2PO4/NaOH or II—NaH2PO4/Na2HPO4) with 1% polyvinyl alcohol. 本文的目的是采用能自由流动的吸附剂，来改善作口服剂之用的固体脂质纳米粒的稳定性与物理性能。基于卡维地洛磷酸盐的硬脂酸是由溶剂乳化蒸发技术制得，该过程是在1%的聚乙烯醇产生的ph值为7.2的缓冲池中制备的牛黄胆酸钠中完成的。 |
3楼2011-01-09 18:51:08
4楼2011-01-10 00:05:25
